BridgeBio Pharma (2CL.F) Q1 2025 Earnings

20FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.33
-0.95
-0.57
-0.19

Details

Expected EPS
-1.06674147422
Actual EPS
-1.3332339999999998
Surprise EPS
-0.27
Surprise Percent
+24.98%

Description

BridgeBio Pharma (2CL.F) has reported earnings of -1.3332339999999998 per share for Q1 2025.

0 Comments

Share your thoughts